z-logo
open-access-imgOpen Access
MSH6 and PMS2 germ-line pathogenic variants implicated in Lynch syndrome are associated with breast cancer
Author(s) -
Maegan E. Roberts,
Sarah Jackson,
Lisa R. Susswein,
Nur Zeinomar,
Xinran Ma,
Megan L. Marshall,
Amy Stettner,
Becky Milewski,
Zhixiong Xu,
Benjamin D. Solomon,
Mary Beth Terry,
Kathleen S. Hruska,
Rachel T. Klein,
Wendy K. Chung
Publication year - 2018
Publication title -
genetics in medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.509
H-Index - 128
eISSN - 1530-0366
pISSN - 1098-3600
DOI - 10.1038/gim.2017.254
Subject(s) - msh6 , mlh1 , breast cancer , lynch syndrome , medicine , msh2 , oncology , population , pms2 , family history , cancer , gynecology , colorectal cancer , environmental health , dna mismatch repair
An association of Lynch syndrome (LS) with breast cancer has been long suspected; however, there have been insufficient data to address this question for each of the LS genes individually.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom